Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...

The therapy is administered as a single subretinal injection beneath the retina ... which then forms 11-cis-retinal—a ...

Opportunities to implement AI across the entire R&D pipeline The gene therapy development process requires engagement with a large network of partners, including large pharma, small and mid-size ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward ...

Gene therapy — the one-time process of inserting a modified gene to compensate for a faulty gene or change how a patient's cells produce proteins — is a complex procedure in which patients ...

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...

A comprehensive approach, including robust preclinical research and a streamlined regulatory process, is the key ...